These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30188404)

  • 1. 90-90-90 HIV targets: implications for HIV-associated tuberculosis.
    Granich R; Gupta S
    Curr Opin HIV AIDS; 2018 Nov; 13(6):528-537. PubMed ID: 30188404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two diseases, same person: moving toward a combined HIV and tuberculosis continuum of care.
    Granich R; Gupta S
    Int J STD AIDS; 2018 Aug; 29(9):873-883. PubMed ID: 29629649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
    Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI
    Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
    Briggs MA; Emerson C; Modi S; Taylor NK; Date A
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.
    Smith T; Samandari T; Abimbola T; Marston B; Sangrujee N
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e84-93. PubMed ID: 26258564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trend analysis of tuberculosis case notifications with scale-up of antiretroviral therapy and roll-out of isoniazid preventive therapy in Zimbabwe, 2000-2018.
    Takarinda KC; Harries AD; Mutasa-Apollo T; Sandy C; Choto RC; Mabaya S; Mbito C; Timire C
    BMJ Open; 2020 Apr; 10(4):e034721. PubMed ID: 32265241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study.
    Denegetu AW; Dolamo BL
    BMC Public Health; 2014 Jan; 14():52. PubMed ID: 24438508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence and incidence of tuberculosis in people living with the HIV in Mandalay, Myanmar, 2011-2017.
    Phyo KH; Oo MM; Harries AD; Saw S; Aung TK; Moe J; Thuya SS; Mon YY; Min AC; Naing NN; Kyi MS; Aung ST; Oo HN
    Int J Tuberc Lung Dis; 2019 Mar; 23(3):349-357. PubMed ID: 30871667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
    Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
    BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
    Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
    BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
    Aït-Khaled N; Alarcon E; Bissell K; Boillot F; Caminero JA; Chiang CY; Clevenbergh P; Dlodlo R; Enarson DA; Enarson P; Ferroussier O; Fujiwara PI; Harries AD; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Rusen ID; Trébucq A; Van Deun A; Wilson N
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):927-35. PubMed ID: 19723371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.
    Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.
    Sibanda T; Tedla Z; Nyirenda S; Agizew T; Marape M; Miranda AG; Reuter H; Johnson JL; Samandari T
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):178-85. PubMed ID: 23317952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis.
    Freiman JM; Jacobson KR; Muyindike WR; Horsburgh CR; Ellner JJ; Hahn JA; Linas BP
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):405-412. PubMed ID: 29239900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    Kunkel A; Crawford FW; Shepherd J; Cohen T
    AIDS; 2016 Nov; 30(17):2715-2723. PubMed ID: 27782966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.
    Sumner T; Houben RM; Rangaka MX; Maartens G; Boulle A; Wilkinson RJ; White RG
    AIDS; 2016 May; 30(8):1279-86. PubMed ID: 26950316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis and HIV-infection in developing countries.
    Broekmans JF
    Trop Geogr Med; 1991 Jul; 43(3):S13-21. PubMed ID: 1687768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.